The Valley Desk

NCT00105937 · Interventional trial

OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

Overall registry status Completed

Phase 3

Conditions Cancer, Pain

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov